Status:

NOT_YET_RECRUITING

Impact of rTMS on BCI Control in Upper Limb Motor Rehabilitation of Patients With Chronic Stroke

Lead Sponsor:

Institut National de la Santé Et de la Recherche Médicale, France

Conditions:

Chonic Stroke Patients With Motor Impairment of Upper Limb

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

Cerebrovascular accidents (strokes) are a major public health issue. Stroke is the 3rd leading cause of death and the leading cause of disability and loss of autonomy. In France, there are currently 1...

Eligibility Criteria

Inclusion

  • Single Stroke older than 6 months
  • Distal motor deficit of the upper limb (UE-FMA score \< 53) with visible extension of the fingers (Medical Research Council (mRC) score ≥ 2)
  • Right-handed
  • Between 18 and 85 years of age
  • Having given their written consent

Exclusion

  • Patient under tutorship or guardianship, under safeguard of justice, deprived of liberty, pregnant or breast feeding women
  • Life-threatening pathologies or compromising follow-up during the study period
  • Trouble of understanding : score below 12/15 in the Boston Diagnostic Aphasia Examination (BDAE) order execution test
  • Fixed spasticity of finger or carpal flexors (mAS score = 4) or botulinum toxin injection less than 12 weeks old in the forearm or hand
  • History of degenarative neurological pathology or craniectomy
  • Deficient upper limb skin lesion preventing use of mucle stimulation
  • Skin lesion of the scalp preventing EEG placement
  • Participation in biomedical therapeutic research that may affect the recovery of the deficient hand during the study
  • Patient who has previously participated in a therapeutic study rTMS (excluding single shock) or a BCI
  • Patient who does not wish to be informed of a brain abnormality discovered accidentally on MRI

Key Trial Info

Start Date :

May 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2029

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06951035

Start Date

May 1 2025

End Date

April 1 2029

Last Update

April 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institut du Cerveau

Paris, France, 75013